Your browser doesn't support javascript.
loading
A First-in-Human Study To Assess the Safety and Pharmacokinetics of LYS228, a Novel Intravenous Monobactam Antibiotic in Healthy Volunteers.
Osborn, Megan; Stachulski, Noah; Sun, Haiying; Blais, Johanne; Venishetty, Vinay; Raccuglia, Marc; Kankam, Martin; Colvin, Richard; Segal, Florencia.
Afiliação
  • Osborn M; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Stachulski N; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Sun H; Novartis Institutes for BioMedical Research, East Hanover, New Jersey, USA.
  • Blais J; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Venishetty V; Novartis Institutes for BioMedical Research, Hyderabad, India.
  • Raccuglia M; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Kankam M; Vince and Associates Clinical Research, Overland Park, Kansas, USA.
  • Colvin R; Bluebird Bio, Cambridge, Massachusetts, USA.
  • Segal F; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA florencia.segal@novartis.com.
Article em En | MEDLINE | ID: mdl-31061156

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monobactamas / Antibacterianos Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monobactamas / Antibacterianos Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos